Generalized anxiety disorder (GAD) affects roughly 2.7% of U.S. adults in any given year, and about 5.7% will experience it at some point in their lives. That makes it one of the most common mental health conditions in the country, affecting nearly 7 million adults. Yet despite how widespread it is, fewer than half of those people receive treatment.
Prevalence in the U.S.
The most-cited figure comes from the National Institute of Mental Health: 2.7% of American adults had GAD in the past year, and 5.7% will develop it during their lifetime. Those numbers, based on large national surveys, reflect people who meet the full diagnostic threshold, meaning at least six months of excessive, hard-to-control worry accompanied by symptoms like muscle tension, fatigue, restlessness, and sleep problems.
More recent data suggests the number of people being diagnosed is climbing. A study tracking U.S. healthcare records from 2020 to 2023 found that the annual prevalence of GAD diagnoses rose from 5.4% to 6.6% over that period. Looking at a three-year window from 2021 to 2023, the projected prevalence was 10.3%, meaning roughly one in ten adults received a GAD diagnosis at some point during those three years. Part of this increase likely reflects better screening and greater willingness to seek help rather than a pure spike in the condition itself. But the trend is real and significant either way.
Who Gets GAD
Women are diagnosed with GAD at roughly twice the rate of men. Lifetime prevalence is about 5.3% for women compared to 2.8% for men, and the gap is even wider when looking at a single year: 2.7% of women versus 1.2% of men. CDC data from 2019 paints a similar picture. About 19% of women reported anxiety symptoms in the prior two weeks (ranging from mild to severe), compared to about 12% of men. Women were more likely to experience every severity level, from mild symptoms (11.3% vs. 7.6%) through severe symptoms (3.5% vs. 1.9%).
It’s worth noting that these numbers may partly reflect differences in how men and women report and seek care for anxiety rather than a purely biological gap. But across every major study, women consistently show higher rates.
GAD Rarely Comes Alone
One of the most striking things about GAD is how often it overlaps with other conditions. About 59% of people with GAD also meet the criteria for major depression. That overlap is so common that clinicians often screen for both simultaneously. The combination tends to be more disabling than either condition alone, making daily functioning harder and complicating treatment.
GAD also frequently co-occurs with other anxiety disorders, substance use problems, and chronic pain conditions. If you’ve been diagnosed with GAD and feel like something else is going on too, that experience is statistically normal, not unusual.
The Treatment Gap
Despite being both common and treatable, GAD has a large treatment gap. Only about 43% of people with the condition are receiving any form of professional treatment. That means more than half of the roughly 7 million affected adults are managing symptoms on their own, whether by choice, lack of access, or because they haven’t been diagnosed.
Several factors drive this gap. GAD develops gradually, often starting in adolescence or early adulthood, and many people live with chronic worry for years before recognizing it as a diagnosable condition. The symptoms can feel like a personality trait (“I’ve always been a worrier”) rather than something that responds to therapy or medication. There’s also a practical barrier: a formal diagnosis requires six months of persistent, excessive worry plus at least three physical or cognitive symptoms like difficulty concentrating, irritability, muscle tension, restlessness, fatigue, or disrupted sleep. People whose symptoms fluctuate or who don’t seek help during their worst periods may never get identified.
How Severity Breaks Down
Not everyone with anxiety symptoms experiences them at the same intensity. CDC data from 2019 gives a useful snapshot. Among women reporting any anxiety symptoms, about 11.3% had mild symptoms, 4.3% had moderate symptoms, and 3.5% had severe symptoms. Among men, those figures were 7.6%, 2.4%, and 1.9% respectively. In other words, mild anxiety symptoms are far more common than severe ones, but the severe end of the spectrum still affects millions of people.
Severity matters because it predicts how much GAD interferes with work, relationships, and daily routines. People on the mild end may function well with some adjustments, while those with severe GAD often find it difficult to concentrate at work, maintain social connections, or get consistent sleep. The condition tends to wax and wane over time, with periods of relative calm interrupted by flare-ups, often triggered by life stress.
Putting the Numbers in Context
A 2.7% annual prevalence might sound small, but it translates to millions of people at any given time, and the lifetime figure of nearly 6% means GAD is roughly as common as diabetes in the U.S. adult population. When you include the recent upward trend in diagnoses, the real-world numbers are likely higher than older surveys suggest. If you’re wondering whether your experience with chronic, hard-to-control worry is “common enough” to take seriously, the data is clear: it is, and it’s one of the most undertreated conditions in mental health.